Type 1 diabetics face frequent injections and hospital visits due to short insulin half-life

Type 1 diabetics must inject insulin multiple times daily and visit clinics regularly because current insulins have short half-lives (hours to days), creating a massive burden on quality of life and healthcare costs. Existing insulin formulations haven't solved the fundamental problem of requiring constant dosing, forcing patients to choose between treatment adherence and lifestyle freedom. People are actively searching for long-acting solutions (months to years) that would dramatically reduce injection frequency and medical appointments.